A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes

Summary

This study has two parts. Each participant will receive a daily injection of insulin peglispro during one treatment period and a daily injection of insulin glargine during the other treatment period. Each treatment period is 3 to 4 weeks and is followed by procedures to look at how the body uses or stores fats while taking each study drug.

Timeline

Start

2013-10

Primary completion

2014-12

Completion

2014-12

Drugs

Indications